{"ticker": {"uuid": "c3e2c894-7abb-4d11-bdb3-ec0f2589e389", "symbol": "INM", "name": "InMed Pharmaceuticals Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic"}, "articles": [{"title": "ANI Pharmaceuticals' CFO Sold $285,000 in Stock After a 32% Run", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxONWJVazdka1pLb1lzMmstOE1xRDJUOXN6TTZNazlpd0FRejZPN3RLZUdzSC1zREpjRzdoWlVHbkpkaWFXVzRCTnVIRkFfY28zRTl1Q0otekxjUnMySllsa3VsWTdEQkhLQVV1QldHcXpRZ09vSzVHSEFXeEdsZ1RaR252aHU3N0lJSEJET3NESnY2d3IteVR5NFN1cDRvZWtBS2VsakMyVnB6aUdSNkMyUWFzYw?oc=5", "source_name": "The Motley Fool", "published_at": "2026-07-13T01:20:00+00:00", "published_display": "13 Jul 2026 01:20", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "InMed Pharmaceuticals (Nasdaq: INM) refines structure of planned Mentari merger", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxQUF81RW5aRHpXRjNxZ0tyM0RoM0R4NDR4UGRLZy1rQXMzWDQ3YjEySkxLU2lZVlhDYkYzYUxoY0hYZUpmUFMxclpWWnJJM0F0TkNGM0xZWDg0WWZEQW1VbkJPbUpUTVg0cFVvNnhQV2RiRGs1eXNhdGZJNFJCY2dMd3ctNHRMdW9KM083eURXN2s4WGlRT3lOZ1BIbzgyTkc3U0JLUXNNaW9TdVFfRlA4bzZpeHhocU5iQ0lMYzFEUHRZZ25K?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-10T20:07:37+00:00", "published_display": "10 Jul 2026 20:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "InMed Pharmaceuticals (NASDAQ: INM) clarifies Mentari merger structure and targets Q4 2026 closing", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxQM1NYR3BzbkVfbC04UWgyQTU4aGNnYUd2VlVEWGJNWUVkNlZvSFpJU0U1RDJNT2o3dzJiWW1MYjA1N1VJS1NERWEyWlNZNG4yNXVuaUF3SkhOYnpvNC1RS19PQ21HTTJwUGFuazlCOWRnZzktSTM4WmhhQ214ZVhKUWM4VVJTN0pDTmlHcEdSS0wwd2tGbTk3M0RsRWN5RlpLenJtZDNXQkFVSHJISzdLejZnUlc?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-10T20:02:27+00:00", "published_display": "10 Jul 2026 20:02", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "InMed Pharmaceuticals Amends Deal With Mentari Therapeutics", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/inmed-pharmaceuticals-amends-deal-mentari-074034452.html", "source_name": "MT Newswires", "published_at": "2026-07-07T07:40:34+00:00", "published_display": "07 Jul 2026 07:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "InMed Pharmaceuticals and Mentari Therapeutics Announce Amendment to Merger Agreement and Filing of Registration Statement on Form S-4", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/inmed-pharmaceuticals-mentari-therapeutics-announce-222000785.html", "source_name": "TMX Newsfile", "published_at": "2026-07-06T22:20:00+00:00", "published_display": "06 Jul 2026 22:20", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "InMed adjusts Mentari merger terms, files SEC S-4 for vote", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxPRmhNUHNzRHA1bHgwYnpGYlVmZldPM0g5aTJSSXpYNXgtMjhMWW13Z3lHOE5lZWNjTkdtR1YtbHEzY1gtMTBtVlo2R2FpZ0Q0NVJNM0c2bnl5NDMwZVVqS21neHp5VmlSRVgwd003ZkdndGwzY1RiRUM1TFdwODV2MVVWMldJU0o1N1d3N1drclpxNmtoc25VOFBoZVBrc3BUbTVtN0ZBLWxDalRxYWFuZThmTWhMMFpJbFJKYg?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-06T07:00:00+00:00", "published_display": "06 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "InMed Pharmaceuticals \u0e41\u0e25\u0e30 Mentari Therapeutics \u0e1b\u0e23\u0e30\u0e01\u0e32\u0e28\u0e41\u0e01\u0e49\u0e44\u0e02\u0e02\u0e49\u0e2d\u0e15\u0e01\u0e25\u0e07\u0e01\u0e32\u0e23\u0e04\u0e27\u0e1a\u0e23\u0e27\u0e21\u0e01\u0e34\u0e08\u0e01\u0e32\u0e23 \u0e1e\u0e23\u0e49\u0e2d\u0e21\u0e22\u0e37\u0e48\u0e19\u0e41\u0e1a\u0e1a\u0e41\u0e2a\u0e14\u0e07\u0e23\u0e32\u0e22\u0e01\u0e32\u0e23\u0e02\u0e49\u0e2d\u0e21\u0e39\u0e25\u0e01\u0e32\u0e23\u0e08\u0e14\u0e17\u0e30\u0e40\u0e1a\u0e35\u0e22\u0e19 (Registration Statement) \u0e15\u0e32\u0e21\u0e41\u0e1a\u0e1a Form S-4", "summary": "", "url": "https://news.google.com/rss/articles/CBMiygFBVV95cUxQRHU5TFFINDcweXJmLXRyemJtb3MzQk82UUpNMHdxUWlBSXFTWVRDZFV2a2FGeG9vTmpGU0NoZ0RJQThqWU1CclZsS3BVSk9NbGd0Z1V4T3BNd2lHR2dRZnRFYkJaUmVwei1aZkN0bXNSUFh4dVYyUkZHUXpZQmtFYzRmZDBHNWsyVkpTWGVhN3dEVnlHc0lXdWt0bDc3UEs0R3BrOWhNdDFQTnNyb1RCdjJPTm9PSmpIVnVCMHRSS1JmYlVtcWw0Rm9n?oc=5", "source_name": "Moomoo", "published_at": "2026-07-06T07:00:00+00:00", "published_display": "06 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vivo Opportunity increases InMed (INM) stake with open-market share buys", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxNa1Q0ampfOWNhZGFvVXVVNlhmRmRqLXlqMjdpVXEtc2JidjBvUlhudnUtekc5QWpjNFZyNlpaSl95dFpJUTR5dDdjejlzM2NSZjduWVNSbnVZOVdEY3hfS1luanZNeUlkNDNKSEJReEhYVlFZNHhBaURTelBvbnF6NWJUX1dDRWszMlpjYUtSYUdfa0R1bWhvdE5CTnR5dGxucVBSQXdsbnEzXzVJZHFMYU9acDBLbnpMVThB?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-02T07:00:00+00:00", "published_display": "02 Jul 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ADAR1/Manager Daniel Schneeberger reports 24.1% stake in InMed (NASDAQ: INM)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiygFBVV95cUxNdUVibFFxeU90c2ptV1NhRkE1VDV1S09oRzFTOHFjeThZTHp6eEJ5c3MtdGVISUFwZjAwS3NvcElIR2twV0N4Y0RKRUhMNDVqb0Ytb0U2b3lVUDE0Y2lBa3g4eEoxMXd3aVI2dl9QRUhCaFBMbmc3a0JIVXM4cGlpTWpyWV81V1lndjQ0WERwUHB2c21nbnFRcklEc1JUYm4zR21oOHllamo5T3hNS0F0YTg0dkV0SzJ6RXBBOTVHR2kzMDgyaDlIdkp3?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-05T07:00:00+00:00", "published_display": "05 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "InMed Pharmaceuticals Regains Compliance with Nasdaq Continued Listing Requirements", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/inmed-pharmaceuticals-regains-compliance-nasdaq-210000342.html", "source_name": "TMX Newsfile", "published_at": "2026-06-04T21:00:00+00:00", "published_display": "04 Jun 2026 21:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "InMed (INM) major holder ADAR1 reports 331,449 indirect shares on Form 3", "summary": "", "url": "https://news.google.com/rss/articles/CBMiygFBVV95cUxPT1R3bUNRS1V1SXRPbGllZjNhUndUWTBlczJGNVE0RjVzajZNQWlOT2pSRGhaMmMzNkktQ3p6YW45dTlsVW1tV3RHQVY4aEpWdHFKWHEzcWFKdUhjQndHcU5XT1BvTHhjLVp4VDh2SVFabVBGSXp1RVZ4NDNJUEt1ZjZ2VDA3enBqT1I1UUJBQ3dSR3o5X3JISWx3SHJqaDIzcXVwcElsbUhMaW9DNjZ0N0g2eEVXNlNiTS1fMmNQUkV2bGJpNTZNanBn?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "/C O R R E C T I O N -- InMed Pharmaceuticals/", "summary": "", "url": "https://news.google.com/rss/articles/CBMi7AFBVV95cUxNRW16RTEzdXZxU2FSVGRzMC1vSlJMOFFqU3gwcEVTSEt6RWVycElmZElkajVQWlhUa3Fpelp1cGZ0X3dtaDM4Z01LM3JwRHFXak5lVUhRQV9xYTRsMUVoc284eXRuZnhNVzhrN2pRWHpfR1NIRDlWNG9pRjQydkFQNkctbjROaS0tb1IxTXVubVVtMHVmaGVrdFZRTDlCNjgxRUNKU2dNX2NlTjNvZkp0NmZMM1dvOGstTUFuOTFVX3FiSGlHUFFOTTAwcWNXWDJGbDBtVU5VMHoyNV9SYXpSUWVzT055WnpRS2JjSQ?oc=5", "source_name": "PR Newswire", "published_at": "2026-05-20T07:00:00+00:00", "published_display": "20 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "InMed-Mentari Migraine Merger Backed by $290 Million Financing Reshapes Company Strategy (INM)", "summary": "", "url": "https://finance.yahoo.com/m/1a3f4ef1-2a03-3703-94e9-fb61c1352e14/inmed-mentari-migraine-merger.html", "source_name": "InvestorsHub", "published_at": "2026-05-19T14:37:16+00:00", "published_display": "19 May 2026 14:37", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "InMed Pharmaceuticals Amends Preferred Investment Options", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/inmed-pharmaceuticals-amends-preferred-investment-100000976.html", "source_name": "TMX Newsfile", "published_at": "2026-05-19T10:00:00+00:00", "published_display": "19 May 2026 10:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "InMed Pharmaceuticals stock surges on Mentari merger deal", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxQUDhsZ25zR0FBNE1NcElvbWdQSWNLa0JreFJWWFowUkxwVGx5ZkdoMlc1VTVDZ2VsemhxVGE3MjJjbldNbFkwQm5Gd1FfZ1JXNm1vSVJyUFk5b2NhMEFiVWdOckJEX0lUMFdzbXBiYkhoREZTQkxCb3I1a2hwQzJXaFM4bkY0bnZyQ0FBUzM1WEVOQW9OOUliNzlxa2s2b0liSTJWTFlUeVNrTm9PbDFwT1JjNnBVaWdvWndn?oc=5", "source_name": "Investing.com", "published_at": "2026-05-19T07:00:00+00:00", "published_display": "19 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mentari Therapeutics to go public via InMed (NASDAQ: INM) merger", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxNVjRNM0U3TTFSNXN6MjJyMXFCMHNQWl9GcDJ5TE9CcjBoN0wxTE14bFNLLUZOVThkN1hCZkZQMUtpWmsxSjJ2X1Zob0t1alIzTWlpUHBqV1NzWWREMVluQkhxV0twVUt1QmptaGdNRkFTamhnYVlFYmFMU0dHUHptd2tpcmlkTDl6eU9UNEtha010eE5KU0dJRi1ySTZ5OXRCM0o4QTZYR0NsZU5pc21jSDdJT0M?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-19T07:00:00+00:00", "published_display": "19 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "INM Stock Alert: Halper Sadeh LLC is Investigating Whether InMed Pharmaceuticals, Inc. is Obtaining a Fair Price for its Shareholders", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwJBVV95cUxQWjYyM2pXOWRSa0VrQUFRWDExVmRuRmtiQzFVaXhKSHZ3NFpCUUljWTI5Y0plMVlGSl9ZakluTUE0cW53SUxwQU04ZXo5WXUxNFhJWk9nc21mWGhnX1NOb05zQzZiMy0tVWFLMFlkTGpnQWxmVk9uNE04S3ZNSW1GSFZNYWJGSFdlTktENzQ0VlFBOXpyQ2h2WndSQkp4LUVKREtXcU5PMWptdWtoc2xBTlg5TWg1SkpYVHBDYXJqbk5ZU2ttUDBteVBaWVVEQUJON3dIQ1E2bVJ5YXR4SmFGT1Y4TDJMMlRteTJ5ZUhSNjVHODQ0YWJyXzlIb0F2QWxxRGlhcTF5M3Z6WHJQeFJsdGZseGtQYTQ?oc=5", "source_name": "Business Wire", "published_at": "2026-05-19T07:00:00+00:00", "published_display": "19 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hikma Pharmaceuticals PLC stock (GB00B128J450): Dividend hike and $250M buyback", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxNX2ZfWkxLZDAyQUZNRU55RXhPVHI4dlZrTVVuc3RlV01XV0Jqd21vSDdYU0l3QkJOejBicXhjRXhQcmpkZHlVQ3BsRFE5ZFFxbFV3MWgtLUpndEZKTm1vbTAwaGlYMHEzWVVjNDVUYjFpM1hJS0NRTjdCc3pOeG9VNlg0QThScXpuV3lYNi0xY2NXMnkwdkFMYU8xYWU0WTIyaVdESzRVV2wxaThRazh6bTZCV1RPMWpJWW0tZy1qQUJVNjh6?oc=5", "source_name": "Ad Hoc News", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "InMed Reports Third Quarter Fiscal 2026 Financial Results and Provides Business Update", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/inmed-reports-third-quarter-fiscal-220000267.html", "source_name": "TMX Newsfile", "published_at": "2026-05-06T22:00:00+00:00", "published_display": "06 May 2026 22:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "InMed Pharmaceuticals Receives Nasdaq Notification Regarding Minimum Bid Price Compliance", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxNRXZJUFFPSTU3MzV4SHpLc0hpSVh3ZzcyT041eGoxc0ZVY0czNlBXcXRZcHpHZTUwejJybEtyVmdWNElLTm9ta1pKRzV4bDlnOHA1RHI2ZDEwTmhaRmZFcXRjdmtaNDVDNHBKQ2t2Vmx1WFAwSmZTWUpYMktJUmhyc3hZM1V5ZzR1MlZiSHVVQnpXbmRCeTE2ZmMxSVVLX3pFVEFCZl9oTE82alQ4eHlPdTl5dEJjT2s?oc=5", "source_name": "Investing News Network", "published_at": "2026-03-27T07:00:00+00:00", "published_display": "27 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "InMed Announces Results of 2025 Annual General and Special Meeting", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxOamEtTGRmZGctLU44Qk5OSmxUWE1DOUJkOU56MnJ0eWpqLWhIYUlSekgxNkNfa3MybVJidDlxb0ZCNURPT1ZycTZkQWdWd1JuR3c0VHBkNW1lUjlPVjI4RDNqbkVyUmd5NkJ6X25rX2xaVHpnejdXYmY0alpfTlNGRmtjZEtBMldpYW9xMVFwemZJR0YyUFF2UA?oc=5", "source_name": "Investing News Network", "published_at": "2025-12-17T08:00:00+00:00", "published_display": "17 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "InMed Pharmaceuticals Announces $5 Million Private Placement Priced At-the-Market Under Nasdaq Rules", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2AFBVV95cUxQS2FLMUx4V1I1WW50cUVmM1VCOERpUXVLM202NTl6XzZOWnNvYUdqSHhwektKWl94cVphRXZKUzE5ek9aM3JHeHcyTnFvYlQ0TWNXOGp0dnV6QWIwMEVOUXZnLVlFRFdubXhiRnRNY3U1Q2VSU181SEpaSzBrZzRiWDNrUlEtWlYxTGhUdmlDVHoxWnNPcjJHMmZpNmh0a1hWSHFUZkwyUGZvdkdkQnlhT0tiRVJ6dEo1OHZmbFJXbDc3MDMtZnFxY2k2YnBZMHZ1RThfN1JkVUk?oc=5", "source_name": "TMX Newsfile", "published_at": "2025-06-25T07:00:00+00:00", "published_display": "25 Jun 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "ANI Pharmaceuticals' CFO Sold $285,000 in Stock After a 32% Run", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxONWJVazdka1pLb1lzMmstOE1xRDJUOXN6TTZNazlpd0FRejZPN3RLZUdzSC1zREpjRzdoWlVHbkpkaWFXVzRCTnVIRkFfY28zRTl1Q0otekxjUnMySllsa3VsWTdEQkhLQVV1QldHcXpRZ09vSzVHSEFXeEdsZ1RaR252aHU3N0lJSEJET3NESnY2d3IteVR5NFN1cDRvZWtBS2VsakMyVnB6aUdSNkMyUWFzYw?oc=5", "source_name": "The Motley Fool", "published_at": "2026-07-13T01:20:00+00:00", "published_display": "13 Jul 2026 01:20", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "InMed Pharmaceuticals (Nasdaq: INM) refines structure of planned Mentari merger", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxQUF81RW5aRHpXRjNxZ0tyM0RoM0R4NDR4UGRLZy1rQXMzWDQ3YjEySkxLU2lZVlhDYkYzYUxoY0hYZUpmUFMxclpWWnJJM0F0TkNGM0xZWDg0WWZEQW1VbkJPbUpUTVg0cFVvNnhQV2RiRGs1eXNhdGZJNFJCY2dMd3ctNHRMdW9KM083eURXN2s4WGlRT3lOZ1BIbzgyTkc3U0JLUXNNaW9TdVFfRlA4bzZpeHhocU5iQ0lMYzFEUHRZZ25K?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-10T20:07:37+00:00", "published_display": "10 Jul 2026 20:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "InMed Pharmaceuticals (NASDAQ: INM) clarifies Mentari merger structure and targets Q4 2026 closing", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxQM1NYR3BzbkVfbC04UWgyQTU4aGNnYUd2VlVEWGJNWUVkNlZvSFpJU0U1RDJNT2o3dzJiWW1MYjA1N1VJS1NERWEyWlNZNG4yNXVuaUF3SkhOYnpvNC1RS19PQ21HTTJwUGFuazlCOWRnZzktSTM4WmhhQ214ZVhKUWM4VVJTN0pDTmlHcEdSS0wwd2tGbTk3M0RsRWN5RlpLenJtZDNXQkFVSHJISzdLejZnUlc?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-10T20:02:27+00:00", "published_display": "10 Jul 2026 20:02", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "InMed Pharmaceuticals Amends Deal With Mentari Therapeutics", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/inmed-pharmaceuticals-amends-deal-mentari-074034452.html", "source_name": "MT Newswires", "published_at": "2026-07-07T07:40:34+00:00", "published_display": "07 Jul 2026 07:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "InMed Pharmaceuticals and Mentari Therapeutics Announce Amendment to Merger Agreement and Filing of Registration Statement on Form S-4", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/inmed-pharmaceuticals-mentari-therapeutics-announce-222000785.html", "source_name": "TMX Newsfile", "published_at": "2026-07-06T22:20:00+00:00", "published_display": "06 Jul 2026 22:20", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "InMed adjusts Mentari merger terms, files SEC S-4 for vote", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxPRmhNUHNzRHA1bHgwYnpGYlVmZldPM0g5aTJSSXpYNXgtMjhMWW13Z3lHOE5lZWNjTkdtR1YtbHEzY1gtMTBtVlo2R2FpZ0Q0NVJNM0c2bnl5NDMwZVVqS21neHp5VmlSRVgwd003ZkdndGwzY1RiRUM1TFdwODV2MVVWMldJU0o1N1d3N1drclpxNmtoc25VOFBoZVBrc3BUbTVtN0ZBLWxDalRxYWFuZThmTWhMMFpJbFJKYg?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-06T07:00:00+00:00", "published_display": "06 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "InMed Pharmaceuticals \u0e41\u0e25\u0e30 Mentari Therapeutics \u0e1b\u0e23\u0e30\u0e01\u0e32\u0e28\u0e41\u0e01\u0e49\u0e44\u0e02\u0e02\u0e49\u0e2d\u0e15\u0e01\u0e25\u0e07\u0e01\u0e32\u0e23\u0e04\u0e27\u0e1a\u0e23\u0e27\u0e21\u0e01\u0e34\u0e08\u0e01\u0e32\u0e23 \u0e1e\u0e23\u0e49\u0e2d\u0e21\u0e22\u0e37\u0e48\u0e19\u0e41\u0e1a\u0e1a\u0e41\u0e2a\u0e14\u0e07\u0e23\u0e32\u0e22\u0e01\u0e32\u0e23\u0e02\u0e49\u0e2d\u0e21\u0e39\u0e25\u0e01\u0e32\u0e23\u0e08\u0e14\u0e17\u0e30\u0e40\u0e1a\u0e35\u0e22\u0e19 (Registration Statement) \u0e15\u0e32\u0e21\u0e41\u0e1a\u0e1a Form S-4", "summary": "", "url": "https://news.google.com/rss/articles/CBMiygFBVV95cUxQRHU5TFFINDcweXJmLXRyemJtb3MzQk82UUpNMHdxUWlBSXFTWVRDZFV2a2FGeG9vTmpGU0NoZ0RJQThqWU1CclZsS3BVSk9NbGd0Z1V4T3BNd2lHR2dRZnRFYkJaUmVwei1aZkN0bXNSUFh4dVYyUkZHUXpZQmtFYzRmZDBHNWsyVkpTWGVhN3dEVnlHc0lXdWt0bDc3UEs0R3BrOWhNdDFQTnNyb1RCdjJPTm9PSmpIVnVCMHRSS1JmYlVtcWw0Rm9n?oc=5", "source_name": "Moomoo", "published_at": "2026-07-06T07:00:00+00:00", "published_display": "06 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vivo Opportunity increases InMed (INM) stake with open-market share buys", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxNa1Q0ampfOWNhZGFvVXVVNlhmRmRqLXlqMjdpVXEtc2JidjBvUlhudnUtekc5QWpjNFZyNlpaSl95dFpJUTR5dDdjejlzM2NSZjduWVNSbnVZOVdEY3hfS1luanZNeUlkNDNKSEJReEhYVlFZNHhBaURTelBvbnF6NWJUX1dDRWszMlpjYUtSYUdfa0R1bWhvdE5CTnR5dGxucVBSQXdsbnEzXzVJZHFMYU9acDBLbnpMVThB?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-02T07:00:00+00:00", "published_display": "02 Jul 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ADAR1/Manager Daniel Schneeberger reports 24.1% stake in InMed (NASDAQ: INM)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiygFBVV95cUxNdUVibFFxeU90c2ptV1NhRkE1VDV1S09oRzFTOHFjeThZTHp6eEJ5c3MtdGVISUFwZjAwS3NvcElIR2twV0N4Y0RKRUhMNDVqb0Ytb0U2b3lVUDE0Y2lBa3g4eEoxMXd3aVI2dl9QRUhCaFBMbmc3a0JIVXM4cGlpTWpyWV81V1lndjQ0WERwUHB2c21nbnFRcklEc1JUYm4zR21oOHllamo5T3hNS0F0YTg0dkV0SzJ6RXBBOTVHR2kzMDgyaDlIdkp3?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-05T07:00:00+00:00", "published_display": "05 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "InMed Pharmaceuticals Regains Compliance with Nasdaq Continued Listing Requirements", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/inmed-pharmaceuticals-regains-compliance-nasdaq-210000342.html", "source_name": "TMX Newsfile", "published_at": "2026-06-04T21:00:00+00:00", "published_display": "04 Jun 2026 21:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "InMed (INM) major holder ADAR1 reports 331,449 indirect shares on Form 3", "summary": "", "url": "https://news.google.com/rss/articles/CBMiygFBVV95cUxPT1R3bUNRS1V1SXRPbGllZjNhUndUWTBlczJGNVE0RjVzajZNQWlOT2pSRGhaMmMzNkktQ3p6YW45dTlsVW1tV3RHQVY4aEpWdHFKWHEzcWFKdUhjQndHcU5XT1BvTHhjLVp4VDh2SVFabVBGSXp1RVZ4NDNJUEt1ZjZ2VDA3enBqT1I1UUJBQ3dSR3o5X3JISWx3SHJqaDIzcXVwcElsbUhMaW9DNjZ0N0g2eEVXNlNiTS1fMmNQUkV2bGJpNTZNanBn?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "/C O R R E C T I O N -- InMed Pharmaceuticals/", "summary": "", "url": "https://news.google.com/rss/articles/CBMi7AFBVV95cUxNRW16RTEzdXZxU2FSVGRzMC1vSlJMOFFqU3gwcEVTSEt6RWVycElmZElkajVQWlhUa3Fpelp1cGZ0X3dtaDM4Z01LM3JwRHFXak5lVUhRQV9xYTRsMUVoc284eXRuZnhNVzhrN2pRWHpfR1NIRDlWNG9pRjQydkFQNkctbjROaS0tb1IxTXVubVVtMHVmaGVrdFZRTDlCNjgxRUNKU2dNX2NlTjNvZkp0NmZMM1dvOGstTUFuOTFVX3FiSGlHUFFOTTAwcWNXWDJGbDBtVU5VMHoyNV9SYXpSUWVzT055WnpRS2JjSQ?oc=5", "source_name": "PR Newswire", "published_at": "2026-05-20T07:00:00+00:00", "published_display": "20 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "InMed-Mentari Migraine Merger Backed by $290 Million Financing Reshapes Company Strategy (INM)", "summary": "", "url": "https://finance.yahoo.com/m/1a3f4ef1-2a03-3703-94e9-fb61c1352e14/inmed-mentari-migraine-merger.html", "source_name": "InvestorsHub", "published_at": "2026-05-19T14:37:16+00:00", "published_display": "19 May 2026 14:37", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "InMed Pharmaceuticals Amends Preferred Investment Options", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/inmed-pharmaceuticals-amends-preferred-investment-100000976.html", "source_name": "TMX Newsfile", "published_at": "2026-05-19T10:00:00+00:00", "published_display": "19 May 2026 10:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "InMed Pharmaceuticals stock surges on Mentari merger deal", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxQUDhsZ25zR0FBNE1NcElvbWdQSWNLa0JreFJWWFowUkxwVGx5ZkdoMlc1VTVDZ2VsemhxVGE3MjJjbldNbFkwQm5Gd1FfZ1JXNm1vSVJyUFk5b2NhMEFiVWdOckJEX0lUMFdzbXBiYkhoREZTQkxCb3I1a2hwQzJXaFM4bkY0bnZyQ0FBUzM1WEVOQW9OOUliNzlxa2s2b0liSTJWTFlUeVNrTm9PbDFwT1JjNnBVaWdvWndn?oc=5", "source_name": "Investing.com", "published_at": "2026-05-19T07:00:00+00:00", "published_display": "19 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mentari Therapeutics to go public via InMed (NASDAQ: INM) merger", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxNVjRNM0U3TTFSNXN6MjJyMXFCMHNQWl9GcDJ5TE9CcjBoN0wxTE14bFNLLUZOVThkN1hCZkZQMUtpWmsxSjJ2X1Zob0t1alIzTWlpUHBqV1NzWWREMVluQkhxV0twVUt1QmptaGdNRkFTamhnYVlFYmFMU0dHUHptd2tpcmlkTDl6eU9UNEtha010eE5KU0dJRi1ySTZ5OXRCM0o4QTZYR0NsZU5pc21jSDdJT0M?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-19T07:00:00+00:00", "published_display": "19 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "INM Stock Alert: Halper Sadeh LLC is Investigating Whether InMed Pharmaceuticals, Inc. is Obtaining a Fair Price for its Shareholders", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwJBVV95cUxQWjYyM2pXOWRSa0VrQUFRWDExVmRuRmtiQzFVaXhKSHZ3NFpCUUljWTI5Y0plMVlGSl9ZakluTUE0cW53SUxwQU04ZXo5WXUxNFhJWk9nc21mWGhnX1NOb05zQzZiMy0tVWFLMFlkTGpnQWxmVk9uNE04S3ZNSW1GSFZNYWJGSFdlTktENzQ0VlFBOXpyQ2h2WndSQkp4LUVKREtXcU5PMWptdWtoc2xBTlg5TWg1SkpYVHBDYXJqbk5ZU2ttUDBteVBaWVVEQUJON3dIQ1E2bVJ5YXR4SmFGT1Y4TDJMMlRteTJ5ZUhSNjVHODQ0YWJyXzlIb0F2QWxxRGlhcTF5M3Z6WHJQeFJsdGZseGtQYTQ?oc=5", "source_name": "Business Wire", "published_at": "2026-05-19T07:00:00+00:00", "published_display": "19 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hikma Pharmaceuticals PLC stock (GB00B128J450): Dividend hike and $250M buyback", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxNX2ZfWkxLZDAyQUZNRU55RXhPVHI4dlZrTVVuc3RlV01XV0Jqd21vSDdYU0l3QkJOejBicXhjRXhQcmpkZHlVQ3BsRFE5ZFFxbFV3MWgtLUpndEZKTm1vbTAwaGlYMHEzWVVjNDVUYjFpM1hJS0NRTjdCc3pOeG9VNlg0QThScXpuV3lYNi0xY2NXMnkwdkFMYU8xYWU0WTIyaVdESzRVV2wxaThRazh6bTZCV1RPMWpJWW0tZy1qQUJVNjh6?oc=5", "source_name": "Ad Hoc News", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "InMed Reports Third Quarter Fiscal 2026 Financial Results and Provides Business Update", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/inmed-reports-third-quarter-fiscal-220000267.html", "source_name": "TMX Newsfile", "published_at": "2026-05-06T22:00:00+00:00", "published_display": "06 May 2026 22:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "InMed Pharmaceuticals Receives Nasdaq Notification Regarding Minimum Bid Price Compliance", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxNRXZJUFFPSTU3MzV4SHpLc0hpSVh3ZzcyT041eGoxc0ZVY0czNlBXcXRZcHpHZTUwejJybEtyVmdWNElLTm9ta1pKRzV4bDlnOHA1RHI2ZDEwTmhaRmZFcXRjdmtaNDVDNHBKQ2t2Vmx1WFAwSmZTWUpYMktJUmhyc3hZM1V5ZzR1MlZiSHVVQnpXbmRCeTE2ZmMxSVVLX3pFVEFCZl9oTE82alQ4eHlPdTl5dEJjT2s?oc=5", "source_name": "Investing News Network", "published_at": "2026-03-27T07:00:00+00:00", "published_display": "27 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "InMed Announces Results of 2025 Annual General and Special Meeting", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxOamEtTGRmZGctLU44Qk5OSmxUWE1DOUJkOU56MnJ0eWpqLWhIYUlSekgxNkNfa3MybVJidDlxb0ZCNURPT1ZycTZkQWdWd1JuR3c0VHBkNW1lUjlPVjI4RDNqbkVyUmd5NkJ6X25rX2xaVHpnejdXYmY0alpfTlNGRmtjZEtBMldpYW9xMVFwemZJR0YyUFF2UA?oc=5", "source_name": "Investing News Network", "published_at": "2025-12-17T08:00:00+00:00", "published_display": "17 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "InMed Pharmaceuticals Announces $5 Million Private Placement Priced At-the-Market Under Nasdaq Rules", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2AFBVV95cUxQS2FLMUx4V1I1WW50cUVmM1VCOERpUXVLM202NTl6XzZOWnNvYUdqSHhwektKWl94cVphRXZKUzE5ek9aM3JHeHcyTnFvYlQ0TWNXOGp0dnV6QWIwMEVOUXZnLVlFRFdubXhiRnRNY3U1Q2VSU181SEpaSzBrZzRiWDNrUlEtWlYxTGhUdmlDVHoxWnNPcjJHMmZpNmh0a1hWSHFUZkwyUGZvdkdkQnlhT0tiRVJ6dEo1OHZmbFJXbDc3MDMtZnFxY2k2YnBZMHZ1RThfN1JkVUk?oc=5", "source_name": "TMX Newsfile", "published_at": "2025-06-25T07:00:00+00:00", "published_display": "25 Jun 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 72, "total_relevant": 22, "sentiment_summary": {"positive": 2, "negative": 0, "neutral": 20, "score": 51, "total": 22, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "deals", "primary_label": "Deals and strategy", "confidence": 76, "events": [{"event": "deals", "label": "Deals and strategy", "weight": 5.5, "count": 10}, {"event": "general", "label": "Market update", "weight": 4.95, "count": 9}, {"event": "earnings", "label": "Earnings", "weight": 1.1, "count": 2}, {"event": "capital_return", "label": "Capital return", "weight": 0.55, "count": 1}], "positive_events": 2, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 1.64, "latest_week": "2026-07-10", "one_week_move": 5.1, "four_week_move": 8.6, "twelve_week_move": 131.0, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": 1.067304, "market_dynamics_buy_signal": false, "relative_strength": -6.211387, "fair_value_gap": -67.1, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "negative", "expectation_probability": 35.6133, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+5.1% over one week, +8.6% over four weeks, trend active, and below fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "positive", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 58, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Deals and strategy", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Stock Titan", "count": 7}, {"label": "TMX Newsfile", "count": 5}, {"label": "Investing News Network", "count": 2}, {"label": "The Motley Fool", "count": 1}, {"label": "MT Newswires", "count": 1}, {"label": "Moomoo", "count": 1}, {"label": "PR Newswire", "count": 1}, {"label": "InvestorsHub", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 22}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Deals and strategy", "count": 10}, {"label": "Market update", "count": 9}, {"label": "Earnings", "count": 2}, {"label": "Capital return", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "51/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "positive", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Deals and strategy", "tone": "neutral", "text": "76/100 classification confidence."}, {"label": "Company focus", "value": "22", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "+5.1% over one week, +8.6% over four weeks, trend active, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "ANI Pharmaceuticals' CFO Sold $285,000 in Stock After a 32% Run"}], "updated_at": "2026-07-16T11:36:52.367240+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}